Tools
Stock profile

Haleon plc (HLN)

HLN · Latest close $9.08 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$9.08
As of Nov 18, 2026
Tracked funds holding
6 of 149
2026 Q2 13F filings
Opened / added
0 / 4
vs previous quarter
Trimmed / exited
2
vs previous quarter

Haleon plc (HLN) is held by 6 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 4 funds adding and 2 funds trimming or exiting versus the previous quarter. Latest close $9.08 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Harding Loevner · Dodge & Cox Funds · Oakmark Funds — 6 tracked funds hold HLN. See all holders.

Insider and Congress activity

No insider open-market activity or Congress trades reported for this stock in the recent window. Insider trading · Politician trading.

Often held alongside

REINSURANCE GROUP OF AMERICA INC (RGA) · PNC FINANCIAL SERVICES GROUP, INC. (PNC) · TRUIST FINANCIAL CORP (TFC) · WILLIS TOWERS WATSON PLC (WTW) · Envista Holdings Corp (NVST) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Harding Loevner1.39%15,414,796TRIMMED (-1.9%) Q3 filed Nov 16
Dodge & Cox Funds0.73%149,934,507ADDED (+2.3%) Q3 filed Nov 13
Oakmark Funds0.21%16,833,252ADDED (+12.0%) Q3 filed Nov 16
Kahn Brothers Group0.09%58,341ADDED (+3.4%) Q3 filed Nov 16
First Eagle Investment Management0.06%4,224,856ADDED (+4.8%) Q3 filed Nov 10
Tweedy Browne0.05%72,035TRIMMED (-1.0%) Q3 filed Nov 4

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: -3.7% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

11.418.462024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding640 of 8,857 filers
Long-only filers among them640
Change vs 2026 Q1+20 net · 601 entered · 581 exited
Shares reported, all filers591,050,330
Reported value, all filers$5.4B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustryPerfumes, Cosmetics & Other Toilet Preparations (SIC 2844)
Revenue · FY202511.0B GBP
Net income · FY20251.7B GBP
Total assets · FY202532.6B GBP
Shares outstanding8,952,353,648
Market cap (at latest close)$81.3B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Mar 13, 2026.

Short interest

Shares short · Oct 15, 202618,538,062
Share of shares outstanding0.21%
Days to cover1.08

Shares short at recent settlements — Jul 31, 2026: 18.1M · Aug 14, 2026: 13.3M · Aug 31, 2026: 15.4M · Sep 15, 2026: 21.8M · Sep 30, 2026: 24.8M · Oct 15, 2026: 18.5M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Mar 13, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 202695
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 2026<0.1%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 35K · Sep 30, 2026: 0 · Oct 14, 2026: 95.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Mar 13, 2026.

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Dec 29, 2023GlaxoSmithKline (US) TrustAffiliate8,527,104$70.6MDec 27, 2023SEC filing
Dec 5, 2023GSK Master Grantor TrustAffiliate404,599$3.5MDec 5, 2023SEC filing
Nov 3, 2023GlaxoSmithKline Employee TrustAffiliate173,611$1.4MNov 6, 2023SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

Activist disclosure · Schedule 13D

FiledFormPrice change since disclosure
Mar 24, 2025SCHEDULE 13D/A-9.9% (close Mar 25, 2025 → Nov 17, 2026)

Reference close is the first trading day after the filing (Mar 25, 2025). A Schedule 13D reports beneficial ownership, not a purchase — there is no transaction price to show. Source: SEC EDGAR Schedule 13D filings.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Jul 28, 2026BlackRock, Inc.SC 13G/A745,718,6198.5%Jun 30, 2026SEC filing
Feb 10, 2026Wellington Management Group LLPSC 13G/A443,046,6865.0%Dec 31, 2025SEC filing
May 12, 2025Wellington Management Group LLPSC 13G619,234,8186.9%Mar 31, 2025SEC filing
Apr 23, 2025BlackRock, Inc.SC 13G/A663,725,1227.3%Mar 31, 2025SEC filing
Mar 24, 2025Pfizer Inc.SC 13D/A00.0%Mar 21, 2025SEC filing
Mar 20, 2025Pfizer Inc.SC 13D/A661,709,7647.3%Mar 18, 2025SEC filing
Feb 27, 2025Pfizer Inc.SC 13D/A661,709,7647.3%Feb 25, 2025SEC filing
Jan 21, 2025Pfizer Inc.SC 13D/A661,709,7647.3%Jan 17, 2025SEC filing
Jan 16, 2025Pfizer Inc.SC 13D/A1,361,709,76415.0%Jan 14, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: 43 Lobbying Disclosure Act filings named this company as client, 2022–2026; most common issues: Health Issues (43), Taxation/Internal Revenue Code (32), Budget/Appropriations (28).

Federal contracts: no obligated amounts found for this ticker (USASpending, fiscal years 2021–2026).

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

This stock does not currently pass any tracked screen.

Signal record

· Politician BEST — appeared in 1 of the last 20 quarterly lists; latest 2023 Q1, ranked #21 of 50.

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together450.0%-1.1%+5.3%-6.3%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold HLN — ranked by lift, the co-holding pattern described in Methodology: REINSURANCE GROUP OF AMERICA INC (RGA) · PNC FINANCIAL SERVICES GROUP, INC. (PNC) · TRUIST FINANCIAL CORP (TFC) · WILLIS TOWERS WATSON PLC (WTW) · Envista Holdings Corp (NVST) · CHARTER COMMUNICATIONS, INC. /MO/ (CHTR) · DIAGEO PLC (DEO) · UNILEVER PLC (UL).

Recent 8-K filings

No Form 8-K filings for this ticker in the index (Jan 2023 – present).

Related

REINSURANCE GROUP OF AMERICA INC (RGA) · Track Record: how the signals scored · Practice timing on HLN

One email a week: the week’s new filings and research. Subscribe free

← HLLY  ·  HLT →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.